BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22751129)

  • 21. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
    Oka T; Ouchida M; Koyama M; Ogama Y; Takada S; Nakatani Y; Tanaka T; Yoshino T; Hayashi K; Ohara N; Kondo E; Takahashi K; Tsuchiyama J; Tanimoto M; Shimizu K; Akagi T
    Cancer Res; 2002 Nov; 62(22):6390-4. PubMed ID: 12438221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia.
    Yang YL; Lin SR; Chen JS; Lin SW; Yu SL; Chen HY; Yen CT; Lin CY; Lin JF; Lin KH; Jou ST; Hu CY; Chang SK; Lu MY; Chang HH; Chang WH; Lin KS; Lin DT
    Leuk Res; 2010 Jan; 34(1):18-23. PubMed ID: 20109966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
    Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y
    Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sam68 affects cell proliferation and apoptosis of human adult T-acute lymphoblastic leukemia cells via AKT/mTOR signal pathway.
    Wang Q; Li Y; Cheng J; Chen L; Xu H; Li Q; Pang T
    Leuk Res; 2016 Jul; 46():1-9. PubMed ID: 27107742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53.
    Seo J; Chung YS; Sharma GG; Moon E; Burack WR; Pandita TK; Choi K
    Oncogene; 2005 Dec; 24(55):8176-86. PubMed ID: 16261166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.
    Yamazaki H; Xu CW; Naito M; Nishida H; Okamoto T; Ghani FI; Iwata S; Inukai T; Sugita K; Morimoto C
    Biochem Biophys Res Commun; 2011 May; 409(1):14-21. PubMed ID: 21549094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new Aven-ue to DNA-damage checkpoints.
    Gross A
    Trends Biochem Sci; 2008 Nov; 33(11):514-6. PubMed ID: 18829329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
    Uno S; Kinoshita Y; Azuma Y; Tsunenari T; Yoshimura Y; Iida S; Kikuchi Y; Yamada-Okabe H; Fukushima N
    Oncol Rep; 2007 May; 17(5):1189-94. PubMed ID: 17390064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members.
    Laane E; Panaretakis T; Pokrovskaja K; Buentke E; Corcoran M; Söderhäll S; Heyman M; Mazur J; Zhivotovsky B; Porwit A; Grandér D
    Haematologica; 2007 Nov; 92(11):1460-9. PubMed ID: 18024393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aven recognition of RNA G-quadruplexes regulates translation of the mixed lineage leukemia protooncogenes.
    Thandapani P; Song J; Gandin V; Cai Y; Rouleau SG; Garant JM; Boisvert FM; Yu Z; Perreault JP; Topisirovic I; Richard S
    Elife; 2015 Aug; 4():. PubMed ID: 26267306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels.
    Miyashita K; Kitajima K; Goyama S; Kitamura T; Hara T
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2310-2316. PubMed ID: 29278703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.
    Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A
    Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.
    Vilas-Zornoza A; Agirre X; Abizanda G; Moreno C; Segura V; De Martino Rodriguez A; José-Eneriz ES; Miranda E; Martín-Subero JI; Garate L; Blanco-Prieto MJ; García de Jalón JA; Rio P; Rifón J; Cigudosa JC; Martinez-Climent JA; Román-Gómez J; Calasanz MJ; Ribera JM; Prósper F
    Leukemia; 2012 Jul; 26(7):1517-26. PubMed ID: 22307227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes.
    Fisch P; Boehm T; Lavenir I; Larson T; Arno J; Forster A; Rabbitts TH
    Oncogene; 1992 Dec; 7(12):2389-97. PubMed ID: 1461647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bortezomib suppresses the growth of leukemia cells with Notch1 overexpression in vivo and in vitro.
    Huang C; Hu X; Wang L; Lü S; Cheng H; Song X; Wang J; Yang J
    Cancer Chemother Pharmacol; 2012 Dec; 70(6):801-9. PubMed ID: 22996635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell lines.
    Tagawa H; Miura I; Suzuki R; Suzuki H; Hosokawa Y; Seto M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):175-85. PubMed ID: 11979551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel AVEN-NUTM1 fusion gene in acute myeloid leukemia.
    Yuan L; Chen X; Cao X; Wang F; Zhang Y; Ma X; Cao P; Fang J; Chen J; Zhou X; Wu Q; Nie D; Liu M; Liu H
    Int J Lab Hematol; 2021 Aug; 43(4):O207-O210. PubMed ID: 33755317
    [No Abstract]   [Full Text] [Related]  

  • 40. Nitric oxide donor NOC-5 increases XIAP and Aven level in Jurkat cells.
    Starikova EG; Tashireva LA; Novitsky VV; Ryazantseva NV
    Cell Biol Int; 2014 Jul; 38(7):799-802. PubMed ID: 24677341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.